Polpharm’s investment scheme and its already successful operations in the EU, Russia, Kazakhstan, and Central Asia were announced at a September 25 to debut its business operations in Vietnam

It will open a representative office in Hanoi to introduce more than 600 types of pharmaceutical products, predominantly used in treating heart, digestive and mental health diseases.

Rajmund I. Martyniuk, Vice President of the Management Board and Commercial Director for Polpharm Group, highlighted huge potential for his firm’s operation in the Vietnamese market, which he described as a key location for expansion to other ASEAN members.

Davlet Matkerimov, Polpharma Vietnam General Manager, said his group’s presence in Vietnam will help local patients improve their health condition, adding that his firm wants to produce medicines in Vietnam and transfer knowledge and technology to Vietnamese partners.